Sign Out
Telepharmacy in cancer care well-received by patients, caregivers
Certain factors, such as ease of connectivity and timing, influence the experience of patients and caregivers with telepharmacy in cancer care, a study has found.
Certain factors, such as ease of connectivity and timing, influence the experience of patients and caregivers with telepharmacy in cancer care, a study has found.
Ultra-long-acting basal insulin optimizes diabetes management
In an interview with MIMS Doctor, Dr Ka-Yuen Lock, Specialist in Endocrinology, Diabetes and Metabolism in Hong Kong, discussed management of diabetes mellitus (DM), including use of ultra-long-acting insulin, in optimizing glycaemic control. She also shared a case study illustrating improvements in glucose variability and patient’s satisfaction with insulin degludec (IDeg) in type 1 DM (T1DM).
In an interview with MIMS Doctor, Dr Ka-Yuen Lock, Specialist in Endocrinology, Diabetes and Metabolism in Hong Kong, discussed management of diabetes mellitus (DM), including use of ultra-long-acting insulin, in optimizing glycaemic control. She also shared a case study illustrating improvements in glucose variability and patient’s satisfaction with insulin degludec (IDeg) in type 1 DM (T1DM).
Spikevax XBB.1.5
Contents : Andusomeran [COVID-19 mRNA vaccine (nucleoside modified)]
Indications/Uses : Active immunisation to prevent COVID-19 caused by SARS-CoV-2 in individuals ≥12 yr.
Enhertu
Contents : Trastuzumab deruxtecan
Indications/Uses : Monotherapy for the treatment of adult patients w/ unresectable or metastatic HER2 +ve breast cancer who have received ≥1 prior anti-HER2-based regimens. Monotherapy for the treatment of adult patients w/ unresectable or metastatic HER2-low breast cancer who have received prior chemotherapy in the metastatic setting or developed disease recurrence during or w/in 6 mth of completing adjuvant chemotherapy. Monotherapy for the treatment of adult patients w/ advanced HER2 +ve gastric or gastroesophageal junction adenocarcinoma who have received a prior trastuzumab-based regimen.
